- Home
- CCEL vs ZDAI Comparison
CCEL vs ZDAI Comparison
Compare CCEL & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEL | ZDAI |
|---|---|---|
| Founded | 1989 | 2022 |
| Country | United States | Hong Kong |
| Employees | N/A | 33 |
| Industry | Managed Health Care | General Bldg Contractors - Nonresidential Bldgs |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 35.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCEL | ZDAI |
|---|---|---|
| Price | $3.37 | $4.34 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.5K | ★ 528.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.45% | N/A |
| EPS Growth | ★ 104.39 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $25,384,279.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.82 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $3.10 | $0.20 |
| 52 Week High | $7.91 | $6.56 |
Technical Indicators
Market Signals| Indicator | CCEL | ZDAI |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 78.86 |
| Support Level | $3.33 | $0.39 |
| Resistance Level | $3.57 | $6.56 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | 0.01 | 0.41 |
| Stochastic Oscillator | 68.87 | 67.16 |
Price Performance
Historical ComparisonAbout CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.